NCDC Directs Hospitals On Preventive Measures Following Emergence Of New Virus
Hospitals in the country have been directed to strengthen Infection Prevention and Control (IPC) practices, as well as set aside an appropriate isolation room where cases can be quickly isolated while receiving care.
The Director General, Nigeria Centre for Disease Control and Prevention (NCDC) Dr Jide Idris, who disclosed this in in a statement in Abuja, said the directives were given as response to the rapid spread of Human Metapneumovirus (HMPV) in China.
Recent reports indicate a significant rise in HMPV cases in China, as well as increased respiratory infections linked to HMPV in countries such as the United Kingdom (UK), France and Germany, particularly during the winter season.
The UK Health Security Agency (UKHSA) has highlighted a notable rise in hospital admissions due to HMPV-related complications, especially among children under five years and older adults in care homes.
He said the cases indicated the need for heightened preparedness and vigilance.
Dr Idris pointed out that in response to the increased HMPV activity in China and other affected regions, as well as the growing public interest in the matter, the NCDC, in collaboration with the Federal Ministry of Health and Social Welfare, was closely monitoring global developments and had implemented some actions to ensure public health safety.
According to him, the NCDC, in collaboration with the Federal Ministry of Health, World Health Organisation (WHO), the U.S. Centres for Disease Control and Prevention (USCDC), and the UK Health Security Agency (UKHSA) have conducted dynamic risk assessments of the HMPV and the assessment classified the risk as moderate for Nigeria. He observed that the evaluation would inform and guide preparedness efforts, decision-making and response strategies to mitigate potential impacts.
He said HMPV is a respiratory virus that can cause illnesses ranging from mild cold-like symptoms to severe respiratory infections, particularly in young children, older adults and individuals with weakened immune systems, adding that there is no specific antiviral treatment or vaccine for HMPV.
He further informed that the symptoms include cough Fever, nasal congestion, shortness of breath and wheezing.
0
0
